Âîñïàëèòåëüíûå áîëåçíè öåíòðàëüíîé íåðâíîé ñèñòåìû (G00-G09)
Áàêòåðèàëüíûé ìåíèíãèò, íå êëàññèôèöèðîâàííûé â äðóãèõ ðóáðèêàõ
ÀÇÀÐÀÍHEMOFARM KONCERN A.D.
ÀÌÎÊÑÈÑÀЮÁÈÎÕÈÌÈÊ ÎÀÎ
ÀÌÏÈÖÈËËÈÍ-ÀÊÎÑÑÈÍÒÅÇ ÎÀÎ
ÁÀÊËÎÔÅÍPOLPHARMA S.A.
ÁÈÑÅÏÒÎËPHARMACEUTICAL WORKS POLFA IN PABIANICE J.S. Co.
ÂÈÔÅÐÎÍ®ÔÅÐÎÍ ÎÎÎ
ÊËÀÔÎÐÀÍLaboratoires ROUSSEL-DIAMANT
ÊËÈÎÍÃÅÄÅÎÍ ÐÈÕÒÅÐ-ÐÓÑ ÇÀÎ
ÌÀÊÑÈÏÈÌBRISTOL-MYERS SQUIBB S.r.L.
ÌÅÐÎÍÅÌSUMITOMO PHARMACEUTICALS Co Ltd.
ÌÅÒÐÎÍÈÄÀÇÎË-ÀÊÎÑÑÈÍÒÅÇ ÎÀÎ
ÎÔËÎÊÑÀÖÈÍ-ÀÊÎÑÑÈÍÒÅÇ ÎÀÎ
ÎÔËÎÊÑÀÖÈÍÑÈÍÒÅÇ ÎÀÎ
ÑÅËÅÌÈÖÈÍMEDOCHEMIE Ltd.
ÑÓËÜÏÅÐÀÇÎÍPFIZER
ÑÓËÜÒÀÑÈÍ®ÑÈÍÒÅÇ ÎÀÎ
ÒÐÈÕÎÏÎËPOLPHARMA S.A.
ÔÎÐÒÓÌGlaxoSmithKline S.p.A.
ÖÅÔÀÒ®ÑÈÍÒÅÇ ÎÀÎ
ÖÅÔÎÑÈÍ®ÑÈÍÒÅÇ ÎÀÎ
ÖÅÔÒÀÇÈÄÈÌ-ÀÊÎÑÑÈÍÒÅÇ ÎÀÎ
ÖÅÔÒÐÈÀÊÑÎÍ-ÀÊÎÑÑÈÍÒÅÇ ÎÀÎ